1 Gal A,Burchell RK.Diabetes Mellitus and the Kidneys.Vet Clin North Am Small Anim Pract,2023,53:565-580. 2 Simmons D,Immanuel J,Hague WM,et al.Treatment of Gestational Diabetes Mellitus Diagnosed Early in Pregnancy.N Engl J Med,2023,388:2132-2144. 3 Deer E,Herrock O,Campbell N,et al.The role of immune cells and mediators in preeclampsia.Nat Rev Nephrol,2023,19:257-270. 4 Paulsen CP,Bandak E,Edemann-Callesen H,et al.The Effects of Exercise during Pregnancy on Gestational Diabetes Mellitus,Preeclampsia,and Spontaneous Abortion among Healthy Women-A Systematic Review and Meta-Analysis.Int J Environ Res Public Health,2023,20:6069. 5 Xue Y,Yang N,Ma L,et al.Predictive value of the complement factors B and H for women with gestational diabetes mellitus who are at risk of preeclampsia.Pregnancy Hypertens,2022,30:210-214. 6 Li T,Wang W,Li S,et al.Lusianthridin Exerts Streptozotocin-Induced Gestational Diabetes Mellitus in Female Rats via Alteration of TLR4/MyD88/NF-κB Signaling Pathway.J Oleo Sci,2023,72:775-785. 7 邵大祥.糖化血红蛋白、血清C肽联合检测在糖尿病诊断中的价值.临床医学研究与实践,2023,8:85-88. 8 刘嘉慧,刘靖.2023年欧洲高血压学会新版高血压管理指南简评.中华高血压杂志,2023,31:908-910. 9 Retnakaran R,Ye C,Hanley AJ,et al.Treatment of Gestational Diabetes Mellitus and Maternal Risk of Diabetes After Pregnancy.Diabetes Care,2023,46:587-592. 10 Liu YH,Zhang YS,Chen JY,et al.Comparative effectiveness of prophylactic strategies for preeclampsia:a network meta-analysis of randomized controlled trials.Am J Obstet Gynecol,2023,228:535-546.11 Samanth R,Shenoy V,Sreedharan S,et al.Effect of Preeclampsia and Gestational diabetes mellitus on Neonatal Distortion Product Otoacoustic Emissions:A Tertiary Care Center Study.Ann Otol Rhinol Laryngol,2023,132:985-995. 12 Qin Y,Bily D,Aguirre M,et al.Understanding PPARγ and Its Agonists on Trophoblast Differentiation and Invasion:Potential Therapeutic Targets for Gestational Diabetes Mellitus and Preeclampsia.Nutrients,2023,15:2459. 13 Xie Y,Zhou W,Tao X,et al.Early Gestational Blood Markers to Predict Preeclampsia Complicating Gestational Diabetes Mellitus.Diabetes Metab Syndr Obes,2023,16:1493-1503. 14 王宝君,郭翔宇,胡燕,等.2型糖尿病患者交感皮肤反应、神经传导速度与空腹血清C肽、FGF21、补体因子B水平相关性研究.临床和实验医学杂志,2022,21:2167-2170. 15 Shen Y,Li J,Tian H,et al.High level of complement factor Ba within first prenatal test of gestation increases the risk of subsequent gestational diabetes:a propensity score-matched study.Gynecol Endocrinol,2022,38:158-163. 16 Liu T,Zheng W,Wang L,et al.TLR4/NF-κB Signaling Pathway Participates in the Protective Effects of Apocynin on Gestational Diabetes Mellitus Induced Placental Oxidative Stress and Inflammation.Reprod Sci,2020,27:722-730. 17 任春丽,唐兴国,张玉芳,等.血清TLR4及MFG-E8与子痫前期患者表达及发生早期肾损伤的关系.中国实验诊断学,2020,24:1770-1773. 18 吕靖,冯泰山,阿衣古丽·斯马依力.IgG和补体C3联合子宫动脉血流在高危孕妇子痫前期诊断中的临床应用研究.中国妇幼保健,2023,38:751-754. 19 王玲.NF-κB和TLR4在子痫前期患者血清中的表达及其诊断意义.中国处方药,2019,17:161-162. 20 He YD,Xu BN,Wang ML,et al.Dysregulation of complement system during pregnancy in patients with preeclampsia:A prospective study.Mol Immunol,2020,122:69-79. 21 黄巧明.PAPP-A、AFP、NF-κB、TLR4及uE3在子痫前期患者血清中的表达及临床意义.中国现代药物应用,2019,13:64-65. 22 李柯瑾,赵玉荣,杜金龙,等.补体B因子与补体H因子对妊娠期糖尿病患者并发子痫前期预测价值.临床军医杂志,2023,51:638-640.